Skip to main navigation
Skip to search
Skip to main content
United Arab Emirates University Home
Search content at United Arab Emirates University
Home
Research units
Researchers
Projects
Research output
Datasets
Activities
Press/Media
Prizes
Impacts
The anti-atherogenic effects of thiazolidinediones
Lily Stojanovska
, Suzy Y. Honisett
, Paul A. Komesaroff
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The anti-atherogenic effects of thiazolidinediones'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Atherogenesis
100%
Thiazolidinedione
100%
Non Insulin Dependent Diabetes Mellitus
83%
Rosiglitazone
50%
Pioglitazone
50%
Insulin Resistance
33%
Transcription Factors
16%
Disease
16%
Diabetes Mellitus
16%
Cardiovascular Disease
16%
Hyperglycemia
16%
Glycosylated Hemoglobin
16%
Anti-Inflammatory Drug
16%
Peroxisome Proliferator Activated Receptor
16%
Hypotension
16%
Hyperinsulinemia
16%
Insulin Sensitizing Agent
16%
Impaired Glucose Tolerance
16%
Biochemistry, Genetics and Molecular Biology
Thiazolidinedione
100%
Rosiglitazone
50%
Pioglitazone
50%
Insulin Resistance
33%
Lipid Profile
33%
Glycemic Control
33%
Hyperglycemia
16%
Impaired Glucose Tolerance
16%
Glycated Hemoglobin
16%
Metabolic Pathway
16%
Blood Pressure
16%
Peroxisome Proliferator-Activated Receptor
16%
Transcription Factors
16%
Glucose Metabolism
16%
Insulin Metabolism
16%
Postmenopause
16%
Artery Compliance
16%
Keyphrases
Large Arteries
16%
Metabolism Parameters
16%
Ligand-activated Transcription Factors
16%
Agonistic Effect
16%